Niemann Pick C1 Like Protein 1 H2 2016 Analysis with Drug Profile, MOA, ROA & Molecule Type

Hexa Reports
Market Research Reports and Insightful Company Profiles
Niemann Pick C1 Like Protein 1 H2 2016 Analysis
with Drug Profile, MOA, ROA & Molecule Type
Niemann Pick C1 Like Protein 1 – Pipeline Review, H2 2016, provides an overview of the Niemann Pick C1
Like Protein 1 pipeline landscape. The report provides comprehensive information on the therapeutics
under development for Niemann Pick C1 Like Protein 1, complete with analysis by stage of development,
drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.
Browse more detail information about Niemann Pick C1 Like Protein 1 Market at:
http://www.hexareports.com/report/niemann-pick-c1-like-protein-1-npc1l1-pipeline-review-h2-2016
The report also covers the descriptive pharmacological action of the therapeutics, its complete research
and development history and latest news and press releases. Additionally, the report provides an
overview of key players involved in therapeutic development for Niemann Pick C1 Like Protein 1 and
features dormant and discontinued projects.
Keyplayers:
 Niemann Pick C1 Like Protein 1 (NPC1L1)
 Alvogen Korea Co Ltd
 Chong Kun Dang Pharmaceutical Corp
 Esperion Therapeutics Inc
 Kotobuki Pharmaceutical Co Ltd
 Merck & Co Inc
 Zhejiang Hisun Pharmaceutical Co Ltd
Hexa Reports
Market Research Reports and Insightful Company Profiles
List of Figures of Niemann Pick C1 Like Protein 1 Therapeutics Market Included:
• Number of Products under Development for Niemann Pick C1 Like Protein 1, H2 2016
• Number of Products under Development for Niemann Pick C1 Like Protein 1 -Comparative Analysis, H2
2016
• Number of Products under Development by Companies, H2 2016
• Number of Products under Investigation by Universities/Institutes, H2 2016
• Comparative Analysis by Clinical Stage Development, H2 2016
• Comparative Analysis by Early Stage Products, H2 2016
• Assessment by Monotherapy Products, H2 2016
• Number of Products by Top 10 Targets, H2 2016
• Number of Products by Stage and Top 10 Targets, H2 2016
• Number of Products by Top 10 Mechanism of Actions, H2 2016
• Number of Products by Stage and Top 10 Mechanism of Actions, H2 2016
• Number of Products by Top 10 Routes of Administration, H2 2016
• Number of Products by Stage and Top 10 Routes of Administration, H2 2016
• Number of Products by Top 10 Molecule Types, H2 2016
• Number of Products by Stage and Top 10 Molecule Types, H2 2016
Request Sample Copy of Niemann Pick C1 Like Protein 1 Market Research Report at:
http://www.hexareports.com/report/niemann-pick-c1-like-protein-1-npc1l1-pipeline-review-h22016/request-sample
Scope of this Report:
•The report provides a snapshot of the global therapeutic landscape for Niemann Pick C1 Like Protein 1
•The report reviews Niemann Pick C1 Like Protein 1 targeted therapeutics under development by
companies and universities/research institutes based on information derived from company and industryspecific sources
•The report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages
•The report features descriptive drug profiles for the pipeline products which includes, product
description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental
activities
Reason to Buy:
•Gain strategically significant competitor information, analysis, and insights to formulate effective R&D
strategies
•Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage
•Identify and understand the targeted therapy areas and indications for Niemann Pick C1 Like Protein 1
•Identify the use of drugs for target identification and drug repurposing
•Identify potential new clients or partners in the target demographic
•Develop strategic initiatives by understanding the focus areas of leading companies
Hexa Reports
Market Research Reports and Insightful Company Profiles
Explore Related Reports @
 Potassium Voltage Gated Channel Subfamily KQT Member 2 Pipeline Review:
http://www.hexareports.com/report/potassium-voltage-gated-channel-subfamily-kqt-member-2neuroblastoma-specific-potassium-channel-subunit-alpha-kvlqt2
 Alpha 2C Adrenergic Receptor Pipeline Review, H2 2016:
http://www.hexareports.com/report/alpha-2c-adrenergic-receptor-alpha-2-adrenergic-receptorsubtype-c4
About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom research
and consulting services to a host of key industries across the globe. We offer comprehensive business
intelligence in the form of industry reports which help our clients obtain clarity about their business
environment and enable them to undertake strategic growth initiatives.
Contact Information:
Ryan Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075
Email Us: sales@hexareports.com
Our Website: http://www.hexareports.com/
Visit our Blog: http://hexareports.blogspot.com/
Like our Facebook page: https://www.facebook.com/hexareportsindustry/
Follow us on LinkedIn: https://www.linkedin.com/company/hexa-reports-inc-

Niemann Pick C1 Like Protein 1 (NPC1L1) - Pipeline Review, H2 2016', provides in depth analysis on Niemann Pick C1 Like Protein 1 (NPC1L1) targeted pipeline therapeutics.